« 
 »
Jun 10 2010

PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056

Posted by admin in Polymer News, tags: , , , , , , , , , , ,

PolyMedix to Review Results from Recent Phase 1B LMWH Reversal Clinical Study with Heptagonist PMX-60056
RADNOR, Pa.—-PolyMedix, Inc. , an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has scheduled a webcast for Wednesday, June 9 at 4:00 PM Eastern Time.

Read more on Business Wire via Yahoo! Finance

This entry was posted on Thursday, June 10th, 2010 at 11:34 am and is filed under Polymer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment. Login »

Enter your email address:

Delivered by FeedBurner



Related Posts







    • YOURLINK HERE
    BANNERLINKER
     CLASSIFIEDSPK
     COMPLETEB2B
     DOMAINSTRADE
     EBUSINESSPORT    		 GARMENTSNETWORK
     GEMS22
     GULFVEHICLES
     INDIANCOMMERCIALS
     JOBS22
     KHURRUM    		 OMANTRADERS
     PAKAUTOMOBILES
     PETROSCRAP
     PKBUSINESS
     PKGARMENTS
     SURPLUSOFFERS    		 TOPDEALINGS
     TRADERS22
     UAECLASSIFIEDS
     UAECOMPUTERS
     UAEGARMENTS
     UAEMETALS    		 UAEMOBILES
     UAEPLASTICS
     UAEPROPERTIES
     UAEPROPERTY
     UAEREALESTATE
     UAESTOCKLOTS    		 UAETOPICS
     UAETRADERS
     UAEVEHICLES
     URLSUBMITS
     USACOMMERCIALS
     YOUNGDEALERS